Catalogue of the vascular plants frorn the Ciudad Universitaria de Madrid (Spain)

GAvítAN, R., EcHEvARRíA, JE. & CASAS, 1. [992. Catálogo de la flora vascular de la Ciudad Universitaria de Madrid (España). Bat. Complutensis J8: 175-201 Se presenta un listado de 421 táxones (pertenecientes a 52 familias) presentes en la Ciudad Universitaria de Madrid (España). Este elenco engloba, además de flora espontánea, plantas naturalizadas y adventicias. Se indican para cada especie su biótipo, distribución corológica, tipo de sustrato y caracterización fitosociológica. Los resultados obtenidos muestran que los terófitos tienen un mayor porcentaje de presencia frente al resto, debido -probablemente- a la influencia humana; los elementos mediterráneos se encuentran en proporción similar a los de amplia distribución; la mayoría de los táxones son indiferentes al tipo de sustrato geológico; las comunidades vegetales más abundantes son las anuales y/o ruderales. Un importante numero de táxones se consideran extintos para esta flora por las obras de ampliación de la carretera circunvalatoria, M-30. Por último, se ha seleccionado un conjunto de edafo-indicadores'.GAvILAN, R., EcHEvARRíA, JE. & CAsAs, 1. 1992. Vascular tloristic catalogue of the Ciudad Universitaria of Madrid (Spain). Bat. Cotnplutensis 18: 175-201 A list of 421 taxa belonging to 52 families, from the Ciudad Universitaria of Madrid (Spain) is presented. Spontaneous, naturalized and adventitious plants have been recorded. Life-form, chorological area, soil type and phytosociological characterization are reponed for each species. The results show that therophytes are the most abundant, probably due to the anthropic influence. Mediterranean elements have been found having similar presence than those with wider distribution (Cosmopolitan, Eurasiatic, ..). Most of the taxa are indifferent to geological substratum. Ruderal and annual are the most common community types. It must be also remarked that some of tho.se taxa have probably dissapeared from this area because of works on the M-30 ring road. Finally, a selected list of pedo-indicators taxa is included. Este trabajo se ha realizado en el marco del Proyecto de Investigación financiado por la Consejería de Educación de la Comunidad de Madrid n' CO 12/90. Botánica Complutensis 18:175-201. Edit. Universidad Complulense 1993 176 Rosario Gavilán, man E. Echevarría & lnntarulada Casa

Genetic Characterization of Rubella Virus Strains Detected in Spain, 1998-2014

The National Plan for the Elimination of Rubella was implemented in Spain in 2008 using the logistics of the National Plan for the Elimination of Measles that have been employed since year 2000. Molecular characterization of rubella virus (RUBV) is important for disease surveillance and for monitoring elimination of the disease throughout the world. We describe the first complete series of data regarding the circulation of RUBV genotypes in Spain. The 739-nucleotide fragment designated by the WHO for RUBV genotyping was sequenced in 88 selected cases collected from 1998 to 2014. Five genotypes were identified: 1E, 2B, 1J, 1I, and 1a. Genotype 1E was predominant between 1998 and 2003 but was replaced by genotype 2B, which was detected in sporadic cases in 2004, 2006, 2008, 2012, 2013 and 2014. There was an outbreak of genotype 2B in Algeciras (Andalusia) in 2008. Genotype 1J caused an outbreak in Madrid in 2004/2005 and sporadic cases in 2005 and 2007. Genotype 1I was found to have infected an immune-suppressed patient with neurological symptoms in 2008. Finally, vaccine strain RA 27/3 was detected in three sporadic cases, two of them immune-suppressed and without a recent history of vaccination. This suggests that during these years there were a series of imported sporadic cases and outbreaks, confirming the findings of epidemiological data analysis. The importation sources were generally consistent with our geographic and cultural ties, mainly with Europe (genotypes 1E, 2B, 1I) and Latin America (1J)

Detection of rhabdovirus viral RNA in oropharyngeal swabs and ectoparasites of spanish bats

Rhabdoviruses infect a variety of hosts, including mammals, birds, reptiles, fish, insects and plants. As bats are the natural host for most members of the genus Lyssavirus, the specificity of the amplification methods used for active surveillance is usually restricted to lyssaviruses. However, the presence of other rhabdoviruses in bats has also been reported. In order to broaden the scope of such methods, a new RT-PCR, able to detect a diverse range of rhabdoviruses, was designed. The method detected 81 of 86 different rhabdoviruses. In total, 1488 oropharyngeal bat swabs and 38 nycteribiid samples were analysed, and 17 unique rhabdovirus-related sequences were detected. Phylogenetic analysis suggested that those sequences detected in bats did not constitute a monophyletic group, even when originating from the same bat species. However, all of the sequences detected in nycteribiids and one sequence obtained from a bat did constitute a monophyletic group with Drosophila melanogaster sigma rhabdovirus. © 2013 Crown.Peer Reviewe

Discovery of an Ebolavirus-Like Filovirus in Europe

Filoviruses, amongst the most lethal of primate pathogens, have only been reported as natural infections in sub-Saharan Africa and the Philippines. Infections of bats with the ebolaviruses and marburgviruses do not appear to be associated with disease. Here we report identification in dead insectivorous bats of a genetically distinct filovirus, provisionally named Lloviu virus, after the site of detection, Cueva del Lloviu, in Spain

Endemic Circulation of European Bat Lyssavirus Type 1 in Serotine Bats, Spain

To determine the presence of European bat lyssavirus type 1 in southern Spain, we studied 19 colonies of serotine bats (Eptesicus isabellinus), its main reservoir, during 1998–2003. Viral genome and antibodies were detected in healthy bats, which suggests subclinical infection. The different temporal patterns of circulation found in each colony indicate independent endemic circulation

The MARAS dataset, vegetation and soil characteristics of dryland rangelands across Patagonia

We present the MARAS (Environmental Monitoring of Arid and Semiarid Regions) dataset, which stores vegetation and soil data of 426 rangeland monitoring plots installed throughout Patagonia, a 624.500 km2 area of southern Argentina and Chile. Data for each monitoring plot includes basic climatic and landscape features, photographs, 500 point intercepts for vegetation cover, plant species list and biodiversity indexes, 50-m line-intercept transect for vegetation spatial pattern analysis, land function indexes drawn from 11 measures of soil surface characteristics and laboratory soil analysis (pH, conductivity, organic matter, N and texture). Monitoring plots were installed between 2007 and 2019, and are being reassessed at 5-year intervals (247 have been surveyed twice). The MARAS dataset provides a baseline from which to evaluate the impacts of climate change and changes in land use intensity in Patagonian ecosystems, which collectively constitute one of the world´s largest rangeland areas. This dataset will be of interest to scientists exploring key ecological questions such as biodiversity-ecosystem functioning relationships, plant-soil interactions and climatic controls on ecosystem structure and functioning.Setup of the network was funded by by the Project GEF Patagonia PNUD ARG 07/G35 (2008–2014) “Sustainable Management of Arid and Semiarid systems for desertification control in Patagonia” Argentina. Further funding was assigned by INTA Project Observatorios de Sustentabilidad Rural PNNAT-1128035, Fundación Argeninta Proyecto Observatorio de (2015–2016) and Ley 25.422 para la Recuperación de la Ganadería Ovina (2017–2019) of Argentina. Erwin Domínguez was funded by Ministerio de Agricultura through the “Sistemas de Praderas Estepáricas de Zonas Frías de Chile” Project 502093-70. Fernando T. Maestre acknowledges support from the European Research Council (ERC Grant agreements 242658 [BIOCOM] and 647038 [BIODESERT]) and by Generalitat Valenciana (BIOMORES project, CIDEGENT/2018/041)

HIV coinfection predicts failure of ledipasvir/sofosbuvir in treatment-naïve noncirrhotic patients with HCV genotype

The efficacy of licensed direct-acting antiviral (DAA) regimens is assumed to be the same for hepatitis C virus (HCV)–monoinfected patients (HCV-Mono) and HIV/HCV-coinfected patients (HCV-Co). However, the high sustained viral response (SVR) rates of DAA regimens and the small number of HIV-infected patients included in registration trials have made it difficult to identify predictors of treatment failure, including the presence of HIV. Methods. We compared treatment outcomes for ledipasvir/sofosbuvir (LDV/SOF) against HCV G1 in treatment-naïve HCV-Mono and HCV-Co without cirrhosis in a prospective registry of individuals receiving DAAs for HCV. Results. Up to September 2017, a total of 17 269 patients were registered, and 1358 patients (1055 HCV-Mono/303 HCV-Co) met the inclusion criteria. Significant differences between HCV-Mono and HCV-Co were observed for age, gender, and G1 subtype distribution. Among HCV-Co, 99.0% were receiving antiretroviral therapy. SVR rates for LDV/SOF at 8 weeks did not differ significantly between HCV-Mono and HCV-Co (96.9% vs 94.0%; P = .199). However, the SVR rate for LDV/SOF at 12 weeks was significantly higher for HCV-Mono than HCV-Co (97.2% vs 91.8%; P = .001). A multivariable logistic regression model including age, sex, liver stiffness, G1 subtype, HCV-RNA, HIV, and treatment duration showed the factors associated with treatment failure to be male sex (adjusted odds ratio [aOR], 2.49; 95% confidence interval [CI], 1.27–4.91; P = .008) and HIV infection (aOR, 2.23; 95% CI, 1.13–4.38; P = .020). Conclusions. The results of this large prospective study analyzing outcomes for LDV/SOF against HCV G1 in treatment-naïve noncirrhotic patients suggest that HIV infection is a predictor of treatment failure in patients with chronic hepatitis C.This work was supported by the Spanish AIDS Research Network (RD16/0025/0017), which is included in the Spanish I+D+I Plan and is co-financed by ISCIII-Subdirección General de Evaluacion and European Funding for Regional Development (FEDER), and the Fondo de Investigación de Sanidad en España (FIS)/Instituto de Salud Carlos III (Spanish Health Research Funds; PI17/00657)

Surveillance of Candida spp Bloodstream Infections: Epidemiological Trends and Risk Factors of Death in Two Mexican Tertiary Care Hospitals

Introduction: Larger populations at risk, broader use of antibiotics and longer hospital stays have impacted on the incidence of Candida sp. bloodstream infections (CBSI).Objective: To determine clinical and epidemiologic characteristics of patients with CBSI in two tertiary care reference medical institutions in Mexico City.Design: Prospective and observational laboratory-based surveillance study conducted from 07/2008 to 06/2010.Methods: All patients with CBSI were included. Identification and antifungal susceptibility were performed using CLSI M27-A3 standard procedures. Frequencies, Mann-Whitney U test or T test were used as needed. Risk factors were determined with multivariable analysis and binary logistic regression analysis.Results: CBSI represented 3.8% of nosocomial bloodstream infections. Cumulative incidence was 2.8 per 1000 discharges (incidence rate: 0.38 per 1000 patient-days). C. albicans was the predominant species (46%), followed by C. tropicalis (26%). C. glabrata was isolated from patients with diabetes (50%), and elderly patients. Sixty-four patients (86%) received antifungals. Amphotericin-B deoxycholate (AmBD) was the most commonly used agent (66%). Overall mortality rate reached 46%, and risk factors for death were APACHE II score >= 16 (OR = 6.94, CI95% = 2.34-20.58, p<0.0001), and liver disease (OR = 186.11, CI95% = 7.61-4550.20, p = 0.001). Full susceptibility to fluconazole, AmBD and echinocandins among C. albicans, C. tropicalis, and C. parapsilosis was observed.Conclusions: the cumulative incidence rate in these centers was higher than other reports from tertiary care hospitals from Latin America. Knowledge of local epidemiologic patterns permits the design of more specific strategies for prevention and preemptive therapy of CBSI.Pfizer Inc.Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Med, Mexico City, DF, MexicoHosp Escuela Tegucigalpa, Tegucigalpa, HondurasUniversidade Federal de São Paulo, Escola Paulista Med, Div Infect Dis, São Paulo, BrazilNatl Canc Inst, Div Infect Dis, Mexico City, DF, MexicoUniv Nacl Colombia, Dept Internal Med, Bogota, ColombiaUniv Peruana Cayetano Heredia, Dept Med, Lima, PeruHosp Vargas Caracas, Caracas, VenezuelaCtr Med Caracas, Caracas, VenezuelaUniv Fed Rio de Janeiro, Univ Hosp, Rio de Janeiro, BrazilUniv Texas Med Sch Houston, Mem Hermann Texas Med Ctr, Dept Med, Houston, TX USAUniv Fed Parana, Hosp Clin, BR-80060000 Curitiba, Parana, BrazilUniv Chile, Fac Med, Hosp Luis Calvo Mackenna, Dept Pediat, Santiago 7, ChileUniv Desarrollo, Clin Alemana, Dept Med, Santiago, ChileHosp Clin Jose San Martin, Infect Dis Unit, Buenos Aires, DF, ArgentinaPontificia Univ Catolica Ecuador, Fac Med, Hosp Vozandes, Quito, EcuadorUniversidade Federal de São Paulo, Escola Paulista Med, Div Infect Dis, São Paulo, BrazilPfizer Inc.: INF-168Web of Scienc